Picture of CureVac NV logo

5CV CureVac NV News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: BioNTech Says To Defend Its Work Against All Allegations Of Patent Infringement

July 5 (Reuters) - BioNTech SE  22UAy.DE :
    * BIONTECH SE - STATEMENT ON PATENT INFRINGEMENT LAWSUIT IN
GERMANY
    * BIONTECH SE - BIONTECH VALUES AND RESPECTS VALID
INTELLECTUAL
PROPERTY RIGHTS. BIONTECH'S WORK IS ORIGINAL, AND WE WILL
VIGOROUSLY DEFEND IT AGAINST ALL ALLEGATIONS OF PATENT
INFRINGEMENT
    * BIONTECH SE - WE ARE AWARE THAT IT IS NOT UNUSUAL THAT
OTHER
COMPANIES IN THE PHARMACEUTICAL INDUSTRY, HAVING WITNESSED THE
SUCCESS OF COMIRNATY®, ARE NOW SUGGESTING THAT THE VACCINE
POTENTIALLY INFRINGES THEIR INTELLECTUAL PROPERTY RIGHTS
    * BIONTECH SE - BIONTECH'S WORK IS ORIGINAL, AND WE WILL
VIGOROUSLY DEFEND IT AGAINST ALL ALLEGATIONS OF PATENT
INFRINGEMENT

Source text for Eikon:  ID: 
Further company coverage:  22UAy.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on CureVac NV

See all news